Cargando…

Commentary: Belatacept Does Not Inhibit Follicular T Cell-Dependent B-Cell Differentiation in Kidney Transplantation

Detalles Bibliográficos
Autores principales:	Schroder, Paul M., Ezekian, Brian, Ford, Mandy, Knechtle, Stuart J., Kwun, Jean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704107/ https://www.ncbi.nlm.nih.gov/pubmed/29218048 http://dx.doi.org/10.3389/fimmu.2017.01615

Ejemplares similares

Response: Commentary: Belatacept Does Not Inhibit Follicular T Cell-Dependent B-Cell Differentiation in Kidney Transplantation
por: Baan, Carla C., et al.
Publicado: (2018)

Belatacept Does Not Inhibit Follicular T Cell-Dependent B-Cell Differentiation in Kidney Transplantation
por: de Graav, Gretchen N., et al.
Publicado: (2017)

Belatacept in kidney transplant patients with systemic lupus erythematosus
por: Carrión-Barberà, Irene, et al.
Publicado: (2019)

Desensitization and belatacept-based maintenance therapy in pregnancy-sensitized monkeys receiving a kidney transplant
por: Manook, Miriam, et al.
Publicado: (2023)

Contemporary Strategies and Barriers to Transplantation Tolerance
por: Ezekian, Brian, et al.
Publicado: (2018)

Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients
por: Tawhari, Ibrahim, et al.
Publicado: (2022)

Combined Immunotherapy With Belatacept and BTLA Overexpression Attenuates Acute Rejection Following Kidney Transplantation
por: Zhang, Hengcheng, et al.
Publicado: (2021)

Emerging New Approaches in Desensitization: Targeted Therapies for HLA Sensitization
por: Choi, Ashley Y., et al.
Publicado: (2021)

Harnessing the B Cell Response in Kidney Transplantation – Current State and Future Directions
por: Anwar, Imran J., et al.
Publicado: (2022)

Impaired antigen-specific B-cell responses after Influenza vaccination in kidney transplant recipients receiving co-stimulation blockade with Belatacept
por: Pernin, Vincent, et al.
Publicado: (2022)

Belatacept Conversion in Kidney After Liver Transplantation
por: Cristea, Octav, et al.
Publicado: (2021)

Complement-targeted therapies in kidney transplantation—insights from preclinical studies
por: Anwar, Imran J., et al.
Publicado: (2022)

Belatacept and mediastinal histoplasmosis in a kidney transplant patient
por: Trimarchi, Hernán, et al.
Publicado: (2016)

Time-Limited Therapy with Belatacept in Kidney Transplant Recipients
por: Letellier, Thibault, et al.
Publicado: (2022)

Methylation of FOXP3 TSDR Underlies the Impaired Suppressive Function of Tregs from Long-term Belatacept-Treated Kidney Transplant Patients
por: Alvarez Salazar, Evelyn Katy, et al.
Publicado: (2017)

Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Belatacept in Adult Kidney Transplant Recipients
por: Shen, Jinshan, et al.
Publicado: (2013)

Optimization of de novo belatacept‐based immunosuppression administered to renal transplant recipients
por: Kirk, Allan D., et al.
Publicado: (2020)

Ten Years Experience With Belatacept-Based Immunosuppression After Kidney Transplantation
por: Grannas, Gerrit, et al.
Publicado: (2014)

De Novo Belatacept in a Kidney-After-Heart Transplant Recipient
por: Schenk, Austin D., et al.
Publicado: (2019)

Belatacept-based immunosuppressive regimen in HIV-positive kidney transplant recipients
por: El Sakhawi, Karim, et al.
Publicado: (2020)

Belatacept in Kidney Transplantation: What Are the True Benefits? A Systematic Review
por: Lombardi, Yannis, et al.
Publicado: (2022)

Hepatitis B Virus Reactivation in Kidney Transplant Recipients Treated With Belatacept
por: Schwarz, Chloë, et al.
Publicado: (2023)

Belatacept for Maintenance Immunosuppression in Lung Transplantation
por: Hui, Christine, et al.
Publicado: (2014)

Belatacept in renal transplantation—quo vadis?
por: Westhoff, Timm H.
Publicado: (2016)

T Follicular Regulatory Cell Suppression of T Follicular Helper Cell Function Is Context-Dependent in vitro
por: Lopez-Ocasio, Maria, et al.
Publicado: (2020)

Immunosuppression Has Long-Lasting Effects on Circulating Follicular Regulatory T Cells in Kidney Transplant Recipients
por: Niu, Qian, et al.
Publicado: (2020)

Belatacept conversion in African American kidney transplant recipients with severe renal dysfunction
por: Snyder, Heather S, et al.
Publicado: (2016)

Conversion From Belatacept to Another Immunosuppressive Regimen in Maintenance Kidney-Transplantation Patients
por: Gouin, Anna, et al.
Publicado: (2020)

Immune surveillance and humoral immune responses in kidney transplantation – A look back at T follicular helper cells
por: Subburayalu, Julien
Publicado: (2023)

Potential Application of T-Follicular Regulatory Cell Therapy in Transplantation
por: Dudreuilh, Caroline, et al.
Publicado: (2021)

Heterogeneity within T Cell Memory: Implications for Transplant Tolerance
por: Krummey, Scott M., et al.
Publicado: (2012)

Outcomes With Belatacept Exposure During Pregnancy in Kidney Transplant Recipients: A Case Series
por: Coscia, Lisa, et al.
Publicado: (2023)

Optimal Immunosuppression Strategy in the Sensitized Kidney Transplant Recipient
por: Olaso, Danae, et al.
Publicado: (2021)

Kidney Failure Associates With T Cell Exhaustion and Imbalanced Follicular Helper T Cells
por: Hartzell, Susan, et al.
Publicado: (2020)

Follicular regulatory T cells eliminate HIV-1-infected follicular helper T cells in an IL-2 concentration dependent manner
por: Ollerton, Matthew T., et al.
Publicado: (2022)

Allo-Specific Humoral Responses: New Methods for Screening Donor-Specific Antibody and Characterization of HLA-Specific Memory B Cells
por: Song, Shengli, et al.
Publicado: (2021)

Beneficial Effect of Conversion to Belatacept in Kidney-Transplant Patients with a Low Glomerular-Filtration Rate
por: Belliere, Julie, et al.
Publicado: (2014)

Phase I study of single‐dose pharmacokinetics and pharmacodynamics of belatacept in adolescent kidney transplant recipients
por: Moudgil, Asha, et al.
Publicado: (2019)

T follicular helper cells and T follicular regulatory cells in autoimmune diseases
por: Qi, Jingjing, et al.
Publicado: (2023)

Belatacept As an Alternative to Calcineurin Inhibitors in Patients with Solid Organ Transplants
por: Kumar, Dhiren, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_br0kbm4vcc0mri17qtkfohiioh